|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
Plicamycin inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA] |
CTD |
PMID:25398788 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ankrd37 |
ankyrin repeat domain 37 |
decreases expression |
EXP |
Plicamycin results in decreased expression of ANKRD37 mRNA |
CTD |
PMID:23814049 |
|
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
|
|
G |
Atp7a |
ATPase copper transporting alpha |
multiple interactions decreases expression |
EXP |
Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of ATP7A mRNA] Plicamycin results in decreased expression of ATP7A mRNA |
CTD |
PMID:23814049 |
|
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
ISO |
Plicamycin results in decreased expression of AXL |
CTD |
PMID:18522535 |
|
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
multiple interactions decreases expression |
EXP ISO |
Plicamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BNIP3L mRNA] Plicamycin results in decreased expression of BNIP3L mRNA |
CTD |
PMID:16291751 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [afimoxifene promotes the reaction [ESR1 protein binds to CDH1 promoter]] |
CTD |
PMID:19593637 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [[Cyclosporine co-treated with NGF protein] results in increased expression of CDKN1A mRNA]; Plicamycin inhibits the reaction [SP1 protein binds to CDKN1A promoter] |
CTD |
PMID:24244623 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cybrd1 |
cytochrome b reductase 1 |
multiple interactions decreases expression |
EXP |
Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of CYBRD1 mRNA] Plicamycin results in decreased expression of CYBRD1 mRNA |
CTD |
PMID:23814049 |
|
NCBI chr 3:55,934,874...55,962,132
Ensembl chr 3:55,934,874...55,962,108
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
multiple interactions |
ISO |
[Plicamycin results in decreased activity of SP1 protein] inhibits the reaction [cobaltous chloride results in increased expression of DDIT4 mRNA]; [Plicamycin results in decreased activity of SP1 protein] inhibits the reaction [cobaltous chloride results in increased expression of DDIT4 protein] |
CTD |
PMID:17307335 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
decreases expression |
EXP |
Plicamycin results in decreased expression of EPAS1 mRNA |
CTD |
PMID:23814049 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [Butyric Acid results in increased expression of ERN1 protein] |
CTD |
PMID:26784903 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [afimoxifene promotes the reaction [ESR1 protein binds to CDH1 promoter]] |
CTD |
PMID:19593637 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions decreases expression |
ISO |
Plicamycin inhibits the reaction [Asbestos results in increased expression of F3 mRNA] Plicamycin results in decreased expression of F3 mRNA |
CTD |
PMID:15636197 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Gata4 |
GATA binding protein 4 |
decreases expression |
ISO |
Plicamycin results in decreased expression of GATA4 protein |
CTD |
PMID:34087332 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein] |
CTD |
PMID:26784903 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] |
CTD |
PMID:18953428 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Maoa |
monoamine oxidase A |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [Dexamethasone results in increased expression of MAOA mRNA] |
CTD |
PMID:15946989 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [[Cyclosporine co-treated with NGF protein] results in increased expression of CDKN1A mRNA] |
CTD |
PMID:24244623 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Pfkp |
phosphofructokinase, platelet |
decreases expression |
ISO |
Plicamycin results in decreased expression of PFKP mRNA |
CTD |
PMID:34087332 |
|
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] |
CTD |
PMID:18953428 |
|
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [pitavastatin results in increased expression of PON1 mRNA] |
CTD |
PMID:15690306 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Pon2 |
paraoxonase 2 |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [Chlorpyrifos results in increased expression of PON2 mRNA] |
CTD |
PMID:24979751 |
|
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [PPARD protein results in increased expression of SIRT1 mRNA] |
CTD |
PMID:20160399 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
Plicamycin inhibits the reaction [PPARD protein results in increased expression of SIRT1 mRNA] |
CTD |
PMID:20160399 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
multiple interactions decreases expression |
EXP |
Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of SLC11A2 mRNA] Plicamycin results in decreased expression of SLC11A2 mRNA |
CTD |
PMID:23814049 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc40a1 |
solute carrier family 40 member 1 |
decreases expression multiple interactions |
EXP |
Plicamycin results in decreased expression of SLC40A1 mRNA Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of SLC40A1 mRNA] |
CTD |
PMID:23814049 |
|
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
|
|
G |
Sp1 |
Sp1 transcription factor |
decreases activity multiple interactions decreases expression |
ISO EXP |
Plicamycin results in decreased activity of SP1 protein [Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter]] which results in increased expression of TNFSF10 protein; [Plicamycin results in decreased activity of SP1 protein] inhibits the reaction [cobaltous chloride results in increased expression of DDIT4 mRNA]; [Plicamycin results in decreased activity of SP1 protein] inhibits the reaction [cobaltous chloride results in increased expression of DDIT4 protein]; Plicamycin inhibits the reaction [SP1 protein binds to CDKN1A promoter]; Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter] Plicamycin results in decreased expression of SP1 mRNA Plicamycin results in decreased expression of SP1 protein |
CTD |
PMID:15946989 PMID:17307335 PMID:21603612 PMID:23814049 PMID:24244623 PMID:34087332 More...
|
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Tfrc |
transferrin receptor |
increases expression |
EXP |
Plicamycin results in increased expression of TFRC mRNA |
CTD |
PMID:23814049 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
Plicamycin inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA] |
CTD |
PMID:25398788 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions |
ISO |
[Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter]] which results in increased expression of TNFSF10 protein; Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter] |
CTD |
PMID:21603612 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tnip1 |
TNFAIP3 interacting protein 1 |
decreases expression |
ISO |
Plicamycin results in decreased expression of TNIP1 mRNA |
CTD |
PMID:23464785 |
|
NCBI chr10:39,037,048...39,084,328
Ensembl chr10:39,037,058...39,077,625
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
decreases expression |
ISO |
Mithramycin A decreases expression of XRCC1 mRNA in lung and liver cancer and liver cancer cell lines |
RGD |
PMID:30088263 |
RGD:15036795 |
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|